Symptom Burden in Late-Stage Breast Cancer Patients Treated with CDK Inhibitors Using the PRO-CTCAE
The objective of this study is to use electronic patient-reported outcome (ePRO) and a remote symptom monitoring platform to evaluate symptom differences among late-stage breast cancer patients with and without CDKI treatmen
CareviveMay 18, 2023